Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Catherine G. Ambrose, Medical School (MS), Zimmer, $214,633, Evaluation of Trabecular Metal Implants and Biodegradable Microspheres Impregnated with BMP2.

Noriaki Aoki, School of Health Information Sciences (SHIS), Schull Institute, $42,932, Designing Performance Feedback System for Diabetes Care in Japan.

Roberto C. Arduino, MS, University of Minnesota, $2,404,803, International Phase III IL-2 Study.

Jaroslaw Aronowski, MS and Graduate School of Biomedical Sciences (GSBS), National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke, $891,000, New Target for Stroke: Peroxisome Proliferator Activated Receptor-Gamma.

Ali Azizzadeh, MS, Cook Inc., $353,896, Zenith TX2 Thoracic Endovascular Graft Clinical Study.

Hector G. Balcazar, School of Public Health (SPH), The University of Texas at El Paso, $78,555, Can Promotoras Change Clinical Outcomes for Chronic Disease in El Paso, Texas.

Jose Bayona, MS, Harris County Hospital District, $109,359, Telemedicine Medical Services.

Eric Boerwinkle, SPH, GSBS and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), NIH, $4,920, Myositis Genetic SNP Study.

Staley A. Brod, MS, Biogen Inc., $44,434, Impact of Neutralizing Antibodies on Interferon Responsive Genes Highlights Biomarker (The “Insight” Study).

Theresa L. Byrd, SPH, Texas Tech University Health Sciences Center, $15,000, West Texas Export Center - Pilot Study Title: Understanding System Variables in Colorectal Cancer Screening in Hispanics.

John Y. Choi, MS, University of Cincinnati, $38,127, Interventional Management of Stroke III Study.

Herbert L. Dupont, SPH and GSBS, Salix Pharmaceuticals, $212,078, A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Rifaximin for the Prevention of Travelers’ Diarrhea for Subjects Traveling to Thailand from Switzerland.

Vaunette P. Fay, School of Nursing (SON), Health Resources and Services Administration, $504,581, Comprehensive Geriatric Education Program Improving Practice with Geriatric Resource Nurses.

Kevin W. Finkel, MS, Renamed Biologics Inc., $405,000, A Multi-Center, Randomized, Controlled, Double-Blind, Phase II Study to Assess Safety and Efficacy with the Renal Assist Device in Patients with Acute Renal Failure.

Barbara R. Foorman, MS, NCS Pearson Inc., $160,247, Contracted Services for Student Assessment.

Gerard E. Francisco, MS, Allergan Inc., $32,228, Retrospective Study of Long-Term Efficacy of Repeated Botulinum Toxin-A Injections (Botox Injections).

Adelaide A. Hebert, MS, Immunex Corporation, $118,588, Placebo-Controlled Multicenter Study with Etanercept to Determine Safety and Efficacy in Pediatric Subjects with Plaque Psoriasis.

Keith Hoots, MS and GSBS, Wyeth Pharmaceuticals, $39,097, An Open Label Multi-Center Study to Assess the Efficacy and Safety of B-Domain Deleted Recombinant Factor VIII in Patients with Hemophilia A Undergoing Elective Major Surgery.

Vasanthi Jayaraman, MS and GSBS, NIH, National Institute of General Medical Sciences (NIGMS), $1,182,885, Vibrational Spectroscopic Investigations of Glutamate Receptor.

Barry D. Kahan, MS and GSBS, Novartis Pharmaceuticals Corp.,$1,475,000, Pre-Clinical Development of JAK3 Inhibitor NC1153.

Rodney E. Kellems, MS and GSBS, March of Dimes Birth Defects Foundation, $217,800, Angiotensin Receptor Agonistic Autoantibodies and Preeclampsia.

Bruce C. Kone, MS and GSBS, NIH, National Institute of Diabetes and Digestive and Kidney Diseases, $1,450,104, Regulation of ENAC Transcription.

Richard J. Kulmacz, MS and GSBS, Alcon Laboratories, $22,500, Characteristics of Cyclooxygenase Inhibitors.

Jary M. Lesser, MS, Wyeth-Ayerst Research Inc., $124,815, A Three-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability and Efficacy Study of Three Doses of Lecozotan (SRA-333) SR in Outpatients with Mild to Moderate Alzheimer’s Disease with Donepezil as Active Control.

John W. Lindsey, MS and GSBS, Acorda Therapeutics Inc., $60,346, Open Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects with Multiple Sclerosis Who Participated in the MS F203 Trial.

Michael Lorenz, MS and GSBS, National Academy of Sciences, $50,000, Identification of Isocitrate Lyase Inhibitors as Broad-Spectrum Antimicrobial Drugs.

Yasuhiro Nishiyama, MS and GSBS, NIH, National Institute of Allergy and Infectious Diseases, $445,500, Neutralizing Antibodies Raised by Covalent Immunization.

John O’Brien, MS and GSBS, American Health Assistance Foundation, $200,000, Physiological Uncoupling of Core Gap Junctions.

Joe C. Ontiveros, Dental Branch, Ultradent Products Inc., $37,000, Effect of Accelerated Aging on Color of Composites: In-Vivo and In-Vitro Comparison.

Luis Ostrosky-Zeichner, MS, Merck & Co. Inc., $95,978, New Management Strategies for Fusariosis Using Caspofungin: Reduced-Dose Caspofungin, Combination Therapy with Polyenes, and Prophylaxis in a Murine Model.

Kristin K. Ownby, SON, Texas Higher Education Coordinating Board, $90,000, Promoting Successful Transition from Applicant to Registered Nurse.

Ronald Portman, MS, Boehringer-Ingelheim, $40,000, A Prospective, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy and Pharmacokinetics of Micardis (Telmisartan) in Children and Adolescents with Hypertension after Four Weeks of Treatment.

Jeremy Daniel Slater, MS, Ortho McNeil Pharmaceutical Inc., $101,634, A Double-Blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects with Seizures Indicative of New Onset Epilepsy.

Z. Hong Zhou, MS and GSBS, NIH, NIGMS, $1,039,500, High-Resolution Cryo-em Reconstruction of Large Complexes.

Renewal

Noriaki Aoki, SHIS, Schull Institute, $49,927, Web-Based Patient Registry Development for Quality Assessment of the Care for Trauma, AMI and Stroke in the Emergency Centers in Japan.

Gloria P. Heresi, MS, Harris County, $622,035, Pediatric Primary Medical Care and Medical Case Management.

Alfred L. McAlister, SPH, Texas Department of State Health Services, $2,044,868, TDH Multi-Cultural Tobacco Prevention and Evaluation Studies, Renewal.

Susan M. Ramin, MS, NIH, National Institute of Child Health and Human Development (NICHD) $1,351,600, NICHD Maternal-Fetal Medicine Units Network.

Jon E. Tyson, MS, NIH, NICHD, $1,316,259, Multicenter Network of Neonatal Intensive Care Units.